Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT)

European Urology Oncology(2023)

引用 1|浏览11
暂无评分
摘要
Gallium-68 prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and additional targeted biopsies can be used to detect more aggressive prostate cancer previously missed in patients recently started with active surveillance. Thereby PSMA PET/CT has the potential to further improve risk stratification and patient selection for active surveillance.
更多
查看译文
关键词
Prostate cancer,Active surveillance,Prostate-specific membrane antigen positron emission tomography/computed tomography,Low-risk prostate cancer
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要